Characteristics and distinct prognostic determinants of individuals with hepatosplenic T-cell lymphoma over the past two decades

doi:10.5306/wjco.v15.i6.745

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1203)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-3) series.

Item

Count

PDF

HTML

832

Tables (1-3)

124

Sum=1004

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

126

Sum=154

Jun 24, 2024 (publication date) through Jan 8, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. Jun 24, 2024; 15(6): 745-754
Published online Jun 24, 2024. doi: 10.5306/wjco.v15.i6.745

Table 3 Multivariate cox proportional hazard regression analyses of factors affecting all-cause mortality and hepatosplenic T-cell lymphoma related mortality among patients between 2000 and 2017

Characteristics	Overall mortality adjusted proportional hazard ratio (95% confidence interval)	HSTCL adjusted proportional hazard ratio (95% confidence interval)
Gender
Female	1 (reference)	1 (reference)
Male	0.79 (0.48-1.29)	0.83 (0.49-1.41)
Age at diagnosis, yr
0-39	1 (reference)	1 (reference)
40-59	0.60 (0.32-1.13)	0.62 (0.30-1.26)
60-79	1.32 (0.67-2.58)	1.65 (0.78-3.49)
80+	2.98 (0.88-10.09)	4.72 (1.14-19.54)^a
Race
Non-Hispanic white	1 (reference)	1 (reference)
Non-Hispanic black	1.61 (0.89-2.89)	2.02 (1.08-3.79)^a
Hispanic	1.87 (0.73-4.78)	1.90 (0.69-5.28)
Other	1.59 (0.79-3.19)	1.49 (0.67-3.37)
Tumor stage
Localized	1 (reference)	1 (reference)
Regional	0.69 (0.24-2.01)	1.17 (0.33-4.19)
Distant	1.03 (0.57-1.87)	1.85 (0.87-3.89)
Living area
Counties in metropolitan areas of 1 million persons	1 (reference)	1 (reference)
Counties in metropolitan areas of 250,000 to 1 million persons	1.19 (0.69-2.07)	1.05 (0.55-2.02)
Counties in metropolitan areas of 250000 persons	1.07 (0.44-2.60)	0.68 (0.24-1.94)
Nonmetropolitan counties	2.71 (0.78-9.39)	2.36 (0.50-11.09)
Income per year
$ < $55000	1 (reference)	1 (reference)
$55000-64999	2.72 (0.82-9.07)	2.54 (0.58-11.08)
$65000-74999	1.75 (0.53-5.85)	1.04 (0.23-4.63)
$75000+	1.46 (0.43-4.96)	1.23 (0.28-5.53)
Marital status
Married	1 (reference)	1 (reference)
Single/unknown	0.83 (0.48-1.44)	0.94 (0.51-1.75)
Divorced/separated	1.33 (0.61-2.90)	1.79 (0.77-4.19)
Widowed	1.19 (0.39-3.62)	1.01 (0.26-3.87)
Radiation
No	1 (reference)	1 (reference)
Yes	0.86 (0.35-2.10)	1.07 (0.38-3.01)
Surgery
No	1 (reference)	1 (reference)
Yes	0.83 (0.49-1.40)	0.97 (0.54-1.76)
B symptoms
No	1 (reference)	1 (reference)
Yes	1.66 (0.85-3.24)	2.21 (0.99-4.89)

^aP < 0.05.

HSTCL: Hepatosplenic T-cell lymphoma.

Citation: Bangolo A, Fwelo P, Dey S, Sethi T, Sagireddy S, Chatta J, Goel A, Nagpaul S, Chen EPS, Saravanan C, Gangan S, Thomas J, Potiguara S, Nagesh VK, Elias D, Mansour C, Ratnaparkhi PH, Jain P, Mathew M, Porter T, Sultan S, Abbisetty S, Tran L, Chawla M, Lo A, Weissman S, Cho C. Characteristics and distinct prognostic determinants of individuals with hepatosplenic T-cell lymphoma over the past two decades. World J Clin Oncol 2024; 15(6): 745-754
URL: https://www.wjgnet.com/2218-4333/full/v15/i6/745.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i6.745